RESUMEN
The cellular basis of the genetic control of the immune response to poly(LTyr, LGlu)-polyDLAla--polyLLys [(T,G)-A--L] in SJL (H-2s, low responder) mice has been investigated using T-cell factors. Thymocytes of SJL origin were educated to (T,G)-A--L and tested for their ability to produce an antigen-specific factor capable of cooperating in vivo with bone marrow cells of either SJL or C3H.SW (high responder) origin. SJL T cells were found to be incapable of producing such a cooperative factor, in contrast with results previously obtained with C3H/HeJ (low responders) and C3H.SW strains. Moreover, SJL bone marrow cells did not produce an antibody response to (T,G)-A--L, even when combined with factor produced by high responder (C3H.SW) mice. Thus, both T and B cells appear to be defective in the SJL strain in the response to (T,G)-A--L.
Asunto(s)
Linfocitos B/inmunología , Epítopos , Genes , Inmunidad Celular , Péptidos/inmunología , Linfocitos T/inmunología , Animales , Médula Ósea/inmunología , Células de la Médula Ósea , Técnica de Placa Hemolítica , Ratones , Ratones Endogámicos C3H , Ratones EndogámicosRESUMEN
A culture system is descirbed which provides adequate conditions for in vitro immunization of humand peripheral blood lymphocytes to heterologous erythrocytes. Making use of this method we could obtain, with a number of different donors, an antibody response which peaked at about day 8 of culture with 30-300 plaque-forming cells (PFC) per 10(6) input lymphocytes. However, in a number of experiments poor or negative results were obtained, even with donors that had previously given good response. This variability in the results was shown not to be due to a too low number of precursor cells present in the blood and could be overcome by treating the cells, before initiation of the culture, with a factor produced by mouse T cells educated to sheep erythrocytes (SRBC). Under these conditions a PFC responce was obtained which peaked at about day 8 and which in some experiments could be as high as 20,000 PFC per 10(6) input lymphocytes. Paralleling the increase in PFC was an increase in cell number. The cells recovered from the treated cultures were at all times more numerous than in the nontreated cultures. The height of both the proliferative and antibody-producing responses varied from experiment to experiment, a higher proliferative response, accompanying a higher PFC response. Although the mechanisms that are at the basis of the antibody response in vitro described in this paper still need to be clarified, this system may become a useful tool in studying the immune response in man.
Asunto(s)
Formación de Anticuerpos , Linfocitos/inmunología , Animales , Antígenos , División Celular , Células Cultivadas , Medios de Cultivo , Eritrocitos/inmunología , Humanos , Ratones/inmunología , Mitógenos , Linfocitos T/inmunologíaRESUMEN
Mouse thymus cells, educated to poly(tyrosyl,glutamyl)-polyDLalanyl--polylysyl [(T,G)-A--L], release an antigen-specific factor on brief culture in vitro. The factor cooperates with bone marrow cells in the antibody response to (T,G)-A--L in irradiated recipients. Its mol wt determined from Sephadex G100 chromatography is in the region of 50,000. The factor is removed by specific antigen-coated columns, but not by anti-immunoglobulin (anti-Fab, anti-micro, anti-Fv) adsorbents. The factor is removed by alloantisera directed against the H-2 haplotype of the strain in which it is produced. Moreover, only antisera with specificity for the K side of H-2 were successful in removing the factor activity.
Asunto(s)
Linfocitos B/inmunología , Genes , Antígenos de Histocompatibilidad , Linfocitos T/inmunología , Adsorción , Animales , Anticuerpos Antiidiotipos , Formación de Anticuerpos , Especificidad de Anticuerpos , Membrana Celular/inmunología , Mapeo Cromosómico , Ligamiento Genético , Genotipo , Técnica de Placa Hemolítica , Fragmentos de Inmunoglobulinas , Inmunoglobulina M , Isoanticuerpos , Ratones , Ratones Endogámicos , Péptidos/inmunología , Recombinación GenéticaRESUMEN
Further mapping of the mouse T-cell factor specific for poly(Try,Glu)-polyD-LAla--polyLys is reported. It is shown to be a product of the I-A subregion of the H-2 complex by the use of antisera either raised specifically against or made specific, by absorption, for different regions of the H-2 complex. The factor cooperates across allogeneic barriers, e.g., when factor produced by one strian is combined with bone marrow cells of other H-2 incompatible strains.
Asunto(s)
Mapeo Cromosómico , Antígenos de Histocompatibilidad , Linfocitos T/inmunología , Animales , Formación de Anticuerpos , Antígenos , Células de la Médula Ósea , Trasplante de Médula Ósea , Cruzamientos Genéticos , Femenino , Genes , Ganglios Linfáticos/trasplante , Masculino , Ratones , Péptidos/inmunología , Trasplante de Piel , Bazo/trasplante , Timo/trasplante , Factores de Tiempo , Trasplante HomólogoRESUMEN
We describe a format for production of protein arrays termed 'protein in situ array' (PISA). A PISA is rapidly generated in one step directly from PCR-generated DNA fragments by cell-free protein expression and in situ immobilisation at a surface. The template for expression is DNA encoding individual proteins or domains, which is produced by PCR using primers designed from information in DNA databases. Coupled transcription and translation is carried out on a surface to which the tagged protein adheres as soon as it is synthesised. Because proteins generated by cell-free synthesis are usually soluble and functional, this method can overcome problems of insolubility or degradation associated with bacterial expression of recombinant proteins. Moreover, the use of PCR-generated DNA enables rapid production of proteins or domains based on genome information alone and will be particularly useful where cloned material is not available. Here we show that human single-chain antibody fragments (three domain, V(H)/K form) and an enzyme (luciferase) can be functionally arrayed by the PISA method.
Asunto(s)
ADN/genética , Biosíntesis de Proteínas , Proteínas/análisis , Proteínas/genética , Transcripción Genética , Animales , Western Blotting , Sistema Libre de Células , Clonación Molecular , ADN/metabolismo , Bases de Datos como Asunto , Enzimas Inmovilizadas/biosíntesis , Enzimas Inmovilizadas/genética , Enzimas Inmovilizadas/metabolismo , Biblioteca de Genes , Humanos , Fragmentos de Inmunoglobulinas/biosíntesis , Fragmentos de Inmunoglobulinas/genética , Fragmentos de Inmunoglobulinas/inmunología , Luciferasas/biosíntesis , Luciferasas/genética , Luciferasas/metabolismo , Magnetismo , Ratones , Ratones Transgénicos , Microesferas , Reacción en Cadena de la Polimerasa , Progesterona/inmunología , Estructura Terciaria de Proteína , Proteínas/química , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Solubilidad , Moldes GenéticosRESUMEN
BACKGROUND: Peptostreptococcus magnus protein L (PpL) is a multidomain, bacterial surface protein whose presence correlates with virulence. It consists of up to five homologous immunoglobulin binding domains that interact with the variable (VL) regions of kappa light chains found on two thirds of mammalian antibodies. RESULTS: We refined the crystal structure of the complex between a human antibody Fab fragment (2A2) and a single PpL domain (61 residues) to 2.7 A. The asymmetric unit contains two Fab molecules sandwiching a single PpL domain, which contacts similar VL framework regions of two light chains via independent interfaces. The residues contacted on VL are remote from the hypervariable loops. One PpL-Vkappa interface agrees with previous biochemical data, while the second is novel. Site-directed mutagenesis and analytical-centrifugation studies suggest that the two PpL binding sites have markedly different affinities for VL. The PpL residues in both interactions are well conserved among different Peptostreptococcus magnus strains. The Fab contact positions identified in the complex explain the high specificity of PpL for antibodies with kappa rather than lambda chains. CONCLUSIONS: The PpL-Fab complex shows the first interaction of a bacterial virulence factor with a Fab light chain outside the conventional combining site. Structural comparison with two other bacterial proteins interacting with the Fab heavy chain shows that PpL, structurally homologous to streptococcal SpG domains, shares with the latter a similar binding mode. These two bacterial surface proteins interact with their respective immunoglobulin regions through a similar beta zipper interaction.
Asunto(s)
Complejo Antígeno-Anticuerpo , Proteínas Bacterianas , Proteínas de Unión al ADN/química , Fragmentos Fab de Inmunoglobulinas/química , Peptostreptococcus/química , Secuencia de Aminoácidos , Cristalografía por Rayos X , Humanos , Enlace de Hidrógeno , Inmunoglobulina M/química , Inmunoglobulinas/química , Modelos Moleculares , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Unión Proteica , Estructura Terciaria de ProteínaRESUMEN
The monoclonal anti-progesterone antibody DB3 binds progesterone with nanomolar affinity (Ka approximately 10(9) M-1), suggesting high specificity. However, DB3 also cross-reacts with similar affinity with a subgroup of structurally distinct, progesterone-like steroids. Crystals of the unliganded Fab' and various steroid-Fab' complexes are isomorphous and belong to the hexagonal space group, P6(4)22, with unit cell dimensions of a = b = 135 A, c = 124 A. Structures of free and progesterone-bound Fab' have been determined by X-ray crystallography at 2.7 A resolution using molecular replacement techniques. Progesterone is bound in a hydrophobic pocket formed mainly by the interaction of three complementarity determining regions L1, H2 and H3. The orientation of the ligand in the binding site was aided by both crystallographic and biochemical analyses of substituted steroids. The indole side-chain of TrpH100 of the DB3 has two different conformations, inter-converting "open" and "closed" forms of the antibody combining site. The TrpH100 indole thus appears to be acting as an antibody-derived surrogate ligand for its own hydrophobic binding pocket. These structures provide the first atomic view of how a steroid interacts with a protein and offer a structural explanation for the restriction of the anti-progesterone response to the VGAM3.8 family of VH genes.
Asunto(s)
Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/metabolismo , Fragmentos Fab de Inmunoglobulinas/química , Fragmentos Fab de Inmunoglobulinas/metabolismo , Progesterona/metabolismo , Conformación Proteica , Estructura Secundaria de Proteína , Esteroides/inmunología , Secuencia de Aminoácidos , Animales , Especificidad de Anticuerpos , Sitios de Unión de Anticuerpos , Hibridomas/inmunología , Ratones , Modelos Moleculares , Datos de Secuencia Molecular , Progesterona/inmunología , Difracción de Rayos XRESUMEN
Structures of the Fab' fragment of the anti-progesterone antibody DB3 in complex with five cross-reactive steroids (aetiocholanolone, 5 beta-androstane-3,17-dione, 5 alpha-pregnane-20-one-3 beta-ol-hemisuccinate, progesterone-11 alpha-ol-hemisuccinate and progesterone) have been determined by X-ray crystallography to a maximum resolution of 2.7 A. These different steroids compete with progesterone binding with affinities in the nanomolar range despite substantial differences in their three-dimensional structures. Comparison of the unliganded DB3 Fab' and these five steroid-Fab' complexes reveals that all the steroid ligands bind to an "open" conformation of the Fab' as defined by the orientation of the indole side-chain of TrpH100, whereas in the unliganded or "closed" form the binding site is occluded by TrpH100. Small but significant conformational changes take place in the antibody to maximize the physical and chemical complementarity with each ligand. The various cross-reactive ligands are accommodated in the binding site in two distinct orientations. We term these binding modes syn and anti, as they are defined by the orientation of the steroid beta face relative to TrpH50. In all cases, the steroid D ring is inserted into a hydrophobic cavity formed mainly by TrpH50, TyrH97, TrpH100 and PheH100b; a hydrogen bond interaction with AsnH35 to the keto group at position C17 or C20 orients the steroid in the pocket. The AsnH35 hydrogen bond and the interaction with TrpH50 account for the restricted heavy chain response to immunization with progesterone-like steroids derivatized at the 11 alpha position. Cross-reactivity of the antibody with different steroids is explained by alternative binding pockets for the A ring, which generates different ligand orientations in the binding site. This study suggests which factors are most likely to contribute to the observed antibody specificity, such as linker position and the paucity of functional groups on the immunogenic hapten.
Asunto(s)
Especificidad de Anticuerpos/fisiología , Fragmentos Fab de Inmunoglobulinas/inmunología , Progesterona/inmunología , Conformación Proteica , Esteroides/inmunología , Secuencia de Aminoácidos , Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/metabolismo , Reacciones Antígeno-Anticuerpo , Sitios de Unión de Anticuerpos , Secuencia de Consenso , Reacciones Cruzadas , Cristalografía por Rayos X , Enlace de Hidrógeno , Fragmentos Fab de Inmunoglobulinas/química , Fragmentos Fab de Inmunoglobulinas/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Estructura Molecular , Progesterona/química , Progesterona/metabolismo , Alineación de Secuencia , Esteroides/química , Esteroides/metabolismoRESUMEN
Transgenic mice have been created that carry human immunoglobulin heavy and light chain genes in germline configuration and that have the corresponding endogenous genes silenced. The transgenes are either minigene constructs or large, almost authentic, transloci on yeast artificial chromosomes and undergo B-cell-specific DNA rearrangement and hypermutation in the mouse lymphoid tissue. Monoclonal antibodies with good affinities for human antigens have been obtained after immunisation. These mice may be a future source of human antibodies for therapy.
Asunto(s)
Formación de Anticuerpos , Genes de Inmunoglobulinas , Ingeniería de Proteínas , Animales , Linfocitos B/inmunología , Cromosomas Artificiales de Levadura , Reordenamiento Génico , Humanos , Cadenas Pesadas de Inmunoglobulina/biosíntesis , Cadenas Ligeras de Inmunoglobulina/biosíntesis , Ratones , Ratones Transgénicos , Proteínas Recombinantes/biosíntesisRESUMEN
Passive immunization with a mouse monoclonal antibody against progesterone, designated DB3, blocks pregnancy in several species. We have previously reported that DB3 localizes in the mouse uterine epithelium shortly before normal implantation. This phenomenon is pregnancy dependent and specific for the progesterone antibody. In this study we demonstrate that DB3 is present in the lumen of the uterus 36 h after an i.p. injection; this correlates with the time of maximum antibody reaction on the uterine epithelium. Incubation of DB3 with free progesterone, progesterone-hemisuccinate or progesterone-bovine serum albumin before administration prevented its localization on the epithelium, indicating that the localization requires free progesterone-binding sites and thus probably depends upon progesterone binding. In addition, studies in vitro show that DB3 can effectively bind to progesterone carried by high-affinity progesterone-binding protein purified from coypu plasma. We suggest that specific targeting of DB3 may be through progesterone associated with a progesterone-binding molecule on the membrane of the uterine epithelia. This may be an important part of the mechanism of antibody action against implantation.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Implantación del Embrión , Inmunización Pasiva , Progesterona/inmunología , Útero/inmunología , Animales , Sitios de Unión de Anticuerpos , Proteínas Sanguíneas/metabolismo , Femenino , Técnica del Anticuerpo Fluorescente , Ratones , Ratones Endogámicos BALB C , Progesterona/metabolismo , Unión ProteicaRESUMEN
In antibody-ribosome-mRNA complex (ARM) ribosome display, stable complexes of nascent protein, mRNA and ribosomes are produced in a eukaryotic in vitro expression system, through coupled transcription and translation of DNA lacking a 3' stop codon. Selection of the protein simultaneously captures the relevant mRNA, which is recovered as DNA by coupled reverse transcription-polymerase chain reaction (RT-PCR) performed on the intact complexes. Here, we describe the use of ARM display to select a specific human antibody fragment from a transgenic mouse library. The mice carry unrearranged gene segments of the human heavy (H) and kappa light (L) chain loci, while the endogenous murine H and kappa loci are functionally silenced; they respond to immunisation by production of fully human IgM antibodies. A library encoding human single-chain (sc) antibody (V(H)/K) fragments, in which V(H) domains and kappa light chains were combined at random by PCR, was prepared from spleen cells of transgenic mice immunised with progesterone-bovine serum albumin (BSA). Library diversity was demonstrated by sequencing. Progesterone-binding fragments were selected over five cycles of ARM display and the selected DNA cloned and expressed in Escherichia coli. Soluble V(H)/K fragments obtained in periplasmic extracts had the same specificity as ribosome-bound V(H)/K, supporting the view that folding and specificity of the displayed and soluble proteins are equivalent. The affinity of the expressed V(H)/K was approximately 10(-8) M. Sequencing showed that ARM display selected a single V(H)/V(L) combination (V(H)1-2, Vkappa4-1) and rearrangement, with a few mutational differences between clones. Monoclonal antibodies against progesterone-BSA obtained from hybridomas were encoded by the same V(H) and V(L) segments and had similar properties to the fragments obtained in vitro. The combination of ribosome display and transgenic mouse technologies is a rapid means of generating fully human antibody fragments in vitro for expression and further manipulation.
Asunto(s)
Fragmentos de Inmunoglobulinas/aislamiento & purificación , Biblioteca de Péptidos , Progesterona/inmunología , Ribosomas , Secuencia de Aminoácidos , Animales , Afinidad de Anticuerpos , Especificidad de Anticuerpos , Clonación Molecular , Ensayo de Inmunoadsorción Enzimática , Escherichia coli , Humanos , Hibridomas , Fragmentos de Inmunoglobulinas/biosíntesis , Fragmentos de Inmunoglobulinas/genética , Cadenas Pesadas de Inmunoglobulina/biosíntesis , Cadenas Pesadas de Inmunoglobulina/genética , Cadenas kappa de Inmunoglobulina/biosíntesis , Cadenas kappa de Inmunoglobulina/genética , Ratones , Ratones Transgénicos , Datos de Secuencia Molecular , Albúmina Sérica Bovina/inmunologíaRESUMEN
Anti-progesterone immunization leads to reversible infertility in mice; this can be achieved by passive immunization with a monoclonal antibody to progesterone (DB3), or by active immunization with either a progesterone-protein (bovine serum albumin; BSA) conjugate or anti-idiotype directed against DB3. Recovery of fertility in treated females varied from 39.5 to 75.5 median days after passive or active (progesterone-BSA) immunization respectively. Litter size after the first pregnancy also differed from 8.6 +/- 0.8 to 5.0 +/- 0.6 (mean +/- S.E.M.) per mother after passive or active immunization respectively. When litter size was standardized to a maximum of four pups per litter, aberrant maternal responses were observed in the first 5 days after delivery in 40-70% of the nursing mothers. These responses took the forms of cannibalism and failure to retrieve or to nurse pups and resulted in a high incidence of pup rejection (up to 40%), compared with no rejection in control mothers. When mothers were allowed to keep entire litters, an even higher incidence of pup rejection occurred (51% compared with 8% in controls). There was an apparent relation between the degree of negative maternal behaviour and the progesterone antibody concentration in the circulation during the infertile period. Whereas aberrant behaviour occurred mainly within the first 5 days of lactation, it was significantly reduced thereafter. Aberrant behaviour of the mother towards pups may be a consequence of the presence of residual progesterone antibodies in the circulation which affects the process of progesterone withdrawal at parturition that is essential for the establishment of normal maternal responses to the neonate.
Asunto(s)
Conducta Materna , Progesterona/fisiología , Animales , Femenino , Inmunización Pasiva , Lactancia/fisiología , Tamaño de la Camada/fisiología , Ratones , Embarazo , Progesterona/inmunología , VacunaciónRESUMEN
Anti-progesterone monoclonal antibody prevents the establishment of pregnancy in BALB/c mice by the prevention of implantation when injected i.p. 32 h after mating. To determine the specificity of this effect, mice were injected with immune and non-immune purified mouse immunoglobulins. The results show that anti-implantation efficacy was due to high-affinity antibody which bound progesterone since two further mouse immunoglobulin (Ig) G1 preparations, mouse IgA and mouse IgM which failed to bind the steroid, had no effect on pregnancy rates. From a panel of anti-progesterone monoclonal antibodies, six with a high affinity (affinity constant, 0.24-0.80 litres/nmol) and specificity for progesterone were selected for additional studies. Anti-implantation efficacy for five antibodies was similar, with a 50% effective dose within the range of 0.8-2.0 nmol. Antibody reached high concentrations in plasma within 12 h after i.p. injection, and declined with a half-life of about 80 h. Purified F(ab')2 fragments of antibody also bound progesterone, but were less effective than the native molecule in blocking pregnancy. The results show that implantation in the mouse can be blocked by a high-affinity antibody that binds progesterone and which is removed from the blood at a slow rate.
Asunto(s)
Anticuerpos Monoclonales/fisiología , Especificidad de Anticuerpos , Implantación del Embrión , Progesterona/fisiología , Animales , Anticuerpos Monoclonales/administración & dosificación , Femenino , Ratones , Ratones Endogámicos BALB C , Progesterona/inmunologíaRESUMEN
Monoclonal anti-progesterone antibodies were raised by immunizing mice with progesterone coupled through either the C3, C6 or C11 positions to protein carrier (bovine serum albumin, BSA). The specificity of four antibodies for a range of steroids related to progesterone, some carrying substitutions at various ring positions, was studied by competitive inhibition in an ELISA system. The results demonstrated that the ring coupling position has a determining effect on the cross-reactivity of the antibodies obtained. The patterns of cross-reaction were interpreted in the light of the structure of the combining site of an anti-progesterone antibody (DB3) recently determined by X-ray crystallography, and inferences drawn about the orientation of steroid in the combining sites of the antibodies studied. Specifically, in two antibodies raised against progesterone-11-BSA, the orientation of steroid resembled that of the progesterone-DB3 complex, with positions C11 and C3 exposed and C6 and C20 buried; an antibody raised against progesterone-6-BSA bound steroid in an apparently similar disposition, except that C6 was exposed and C11 buried; finally, in an antibody raised against progesterone-3-BSA, all steroid positions other than C3 were apparently buried in the steroid-antibody complex.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Especificidad de Anticuerpos , Antígenos/química , Progesterona/análogos & derivados , Progesterona/inmunología , Animales , Antígenos/inmunología , Sitios de Unión de Anticuerpos , Unión Competitiva , Cristalografía por Rayos X , Ensayo de Inmunoadsorción Enzimática , Hidroxiprogesteronas/inmunología , Ratones , Ratones Endogámicos BALB C , Modelos Moleculares , Estructura Molecular , Progesterona/química , Albúmina Sérica Bovina/inmunología , Relación Estructura-ActividadRESUMEN
OBJECTIVE: To investigate the prevalence of alpha-fodrin autoantibodies in primary Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) with and without secondary SS, using an in vitro transcription and translation assay (ITT). METHODS: cDNA encoding JS-1, the amino-terminal portion of alpha-fodrin, was used for ITT. Immunoprecipitation was performed with sera from 56 primary SS patients and 67 SLE patients, 14 with and 53 without secondary SS. Correlations to RF, ANA, anti-dsDNA, anti-SS-A and anti-SS-B antibodies, hypergammaglobulinemia, labial salivary gland biopsy grade, extraglandular manifestations and a modified SLE disease activity index (mSLEDAI) were made. RESULTS: Autoantibodies against alpha-fodrin were detected in 16/56 (29%) of primary SS patients and in 25/53 (47%) of sera from SLE patients without secondary SS. In SLE patients with secondary SS the prevalence was 3/14 (21%). None of the blood donors showed alpha-fodrin reactivity. Correlations were found to RF, ANA, anti-dsDNA antibodies and a positive mSLEDAI score. CONCLUSION: The frequency of alpha-fodrin autoantibodies detected by this method is similar in sera from primary SS patients and SLE patients with or without secondary SS. The presence of alpha-fodrin autoantibodies seems to reflect non-organ-specific autoimmunity in primary SS and SLE and to be of limited discriminating value.
Asunto(s)
Autoanticuerpos/análisis , Proteínas Portadoras/inmunología , Lupus Eritematoso Sistémico/inmunología , Proteínas de Microfilamentos/inmunología , Síndrome de Sjögren/inmunología , Bioensayo , Biomarcadores/análisis , Proteínas Portadoras/genética , Línea Celular , ADN Complementario/análisis , Femenino , Humanos , Técnicas In Vitro , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/fisiopatología , Masculino , Proteínas de Microfilamentos/genética , Persona de Mediana Edad , Pruebas de Precipitina , Biosíntesis de Proteínas , Factor Reumatoide/sangre , Índice de Severidad de la Enfermedad , Síndrome de Sjögren/sangre , Síndrome de Sjögren/fisiopatología , Transcripción GenéticaRESUMEN
A monoclonal antibody against progesterone completely blocked pregnancy when rats were injected intraperitoneally at 0.53 mumol/kg/day on days 1 and 2, or on day 11 of a first pregnancy. The antibody was equally effective when injected again during a second pregnancy. There was no evidence for anti-idiotypic antibody production even when the injection of a heterologous (mouse) antibody was repeated in a second pregnancy.
Asunto(s)
Anticuerpos Monoclonales/administración & dosificación , Implantación del Embrión , Preñez/sangre , Progesterona/sangre , Animales , Femenino , Idiotipos de Inmunoglobulinas/análisis , Inyecciones Intraperitoneales , Embarazo , Ratas , Ratas Endogámicas , Factores de TiempoRESUMEN
The diverse strategies adopted among species for the maintenance of luteal function converge to meet the indispensable requirement for this hormone particularly at the time of onset of implantation. What has emerged from immunization studies is the difference that exists between various species in the effects of progesterone depletion. The findings affirm the uterus as a primary site of progesterone action in the preimplantation period of gestation in the mouse, whereas in the hamster the positive feedback by progesterone on pituitary luteotrophin secretion is important in maintaining luteal function and hormone secretion at a level necessary for uterine preparation. The impact of progesterone in the rat seems to be established within 48 h after fertilization, whereas in the ferret the hormone's action ensures a suitable uterine environment in which the early embryo can flourish. Its effects in early pregnancy in the marmoset are ambiguous from the present studies unless it emerges that target organ responses are tuned to low concentrations of active steroid. However, the discoveries in mice of a conserved family of immunoglobulin genes used exclusively by immunogenic forms of progesterone conjugated to proteins to stimulate antibody production, and of antibody binding to the uterine epithelium, reveal systems potentially inimical for embryo survival. The endometrial expression of the proto-oncogene erb-A at a time when the embryo has not yet arrived in the uterus, and of antibody-binding to the uterine epithelium, are early maternal responses whose significance require closer examination. The present findings support the hypothesis that the primary site of action of progesterone during the preimplantation period differs between species, and that it is not only the mother that recognizes, but the embryo that initiates early changes before the onset of implantation 'in the bed of soil that nourishes it', a symbiosis that may yet prove to be a common feature of the adoption of viviparity as a preferred mode of reproduction.
Asunto(s)
Anticuerpos/fisiología , Implantación del Embrión/inmunología , Embarazo/inmunología , Progesterona/fisiología , Animales , Anticuerpos/genética , Femenino , Regulación de la Expresión Génica , Genes de Inmunoglobulinas/fisiología , Humanos , Inmunización Pasiva , Mamíferos , Ratones , Ratones Endogámicos BALB C , Embarazo/genética , Progesterona/inmunología , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/inmunología , Receptores de Progesterona/inmunología , Receptores de Progesterona/fisiología , Receptores de Hormona TiroideaRESUMEN
This is the first crystal structure analysis of a complex between an autoantibody and its autoantigen, and it reveals a mode of interaction never before seen in an antibody-antigen complex. Not only are there relatively few antibody contact residues, contributing perhaps to its very low affinity, but these residues are to be found on only one side of the potential combining site surface. Indeed, so many CDR residues are not involved in Fc binding, including those in the central region of the combining site, that it is easy to envisage that this RF may have another, entirely different, specificity. The antibody may therefore have originated in response to another, as yet unidentified, antigen, and the reactivity with IgG Fc may be an unfortunate cross-reactivity. Certainly some of the CDR residues which do interact with IgG Fc are germline encoded, but significantly one of only two residues in the light chain, Pro56, which makes many contacts with Fc, is a somatic mutation. Since this mutation would appear to make a significant contribution to the binding affinity, it is therefore evidence for an antigen driven response to the IgG Fc in the generation of this autoantibody. The Fc epitope recognised by RF-AN is strikingly similar to the binding sites for the bacterial binding proteins A and G, but the significance of this is not clear. What is clear however is that the epitope does not include any part of the Fc carbohydrate residues, although the structure of the complex does reveal that there is an alteration in the carbohydrate conformation when the galactose residues are absent. Loss of the interaction between the terminal galactose residue on the alpha (1-6) linked branch and the C gamma 2 domain appears to allow the carbohydrate chains to become mobile, at the same time exposing a predominantly hydrophobic patch on the C gamma 2 surface. Accessibility to either the agalactosyl carbohydrate chains or the newly exposed residues may account for the enhanced reactivity for G0-IgG that has been reported for certain RFs, and such an epitope need not be very different to that recognised by RF-AN. In order to understand more completely the effect of the presence or absence of the terminal galactose residue, the fully galactosylated glycoform of Fc must be studied for comparison; this work is underway. It is also important now to study a RF which is known to sense this difference in oligosaccharide composition, and also to study RFs of higher affinity, of the IgG class, and from the synovium. RF-AN was the first RF to be immortalised as a cell line, and in many ways it is a typical RF (in terms of specificity, relationship to germline sequence and affinity), but we must now establish whether the novel structural features revealed in this analysis are indeed typical of other RFs. Only when comparisons can be made between RFs of different origin and with contrasting functional properties will we begin to understand what constitutes a pathogenic RF, and the mechanism by which such auto-reactive antibodies are generated.
Asunto(s)
Fragmentos Fc de Inmunoglobulinas/inmunología , Inmunoglobulina G/inmunología , Factor Reumatoide/química , Factor Reumatoide/inmunología , Sitios de Unión , Cristalografía por Rayos X , Humanos , Inmunoglobulina G/química , Oligosacáridos , Conformación ProteicaRESUMEN
Studies are reported on the nature and action of a suppressor factor with specificity for sheep red cells produced by a mouse T-hybrid cell line. Absorption of the factor with anti-H-2 reagents indicated that it carries determinants coded between the I-J and D loci. The factor was bound well by spleen cells of certain strains (B10, B10.BR), but not others (B10.S); absorption studies with spleen cells of H-2 recombinant strains suggested that a gene contributing to a cellular acceptor site for the factor also mapped in the region between I-J and D. On the other hand, studies of functional suppression of the anti-SRBC response of different strains in vitro indicated that an H-2 gene in the I-A or I-B subregions controlled suppression. Thus, at least two H-2 genes seem to be involved in the suppressive action of this factor.
Asunto(s)
Antígenos H-2/genética , Hibridomas/inmunología , Linfocitos T/inmunología , Animales , Formación de Anticuerpos , Mapeo Cromosómico , Eritrocitos/inmunología , Tolerancia Inmunológica , Ratones , Ovinos , Supresión GenéticaRESUMEN
A panel of murine monoclonal antibodies (MAbs) against porcine growth hormone (pGH) has been raised from BALB/c mice. MAbs were characterized for binding to growth hormones (GH), prolactins (PRL), and placental lactogen (PL) from different species and to the N-terminal peptides of GH. From their patterns of cross-reactivity MAbs were assigned into nine specificity groups. The sharing of pGH epitopes among hormones of different species was related to the sequence similarity to pGH, i.e., overlap was greatest for equine, ruminant, and rodent GHs and least for human GH, ovine, and porcine PRLs, and human PL. Partial epitope mapping was carried out by relating hormone cross-reactivity patterns with amino acid sequences. Two epitopes were localized to interhelical loops, around valine-73 and glycine-130, respectively. Direct mapping with synthetic peptides localized other epitopes (Groups 7, 8, and 9) to the N-terminal region of the GH molecule. Selected MAbs were studied for the enhancement of the somatogenic activity of pGH in the dwarf mouse bioassay, measuring weight gain and sulphate incorporation into costal cartilage. Only those antibodies with specificities for GHs and not PRL or PL showed significant enhancement in this assay.